Diazepam News and Research

RSS

Diazepam is a drug used to treat mild to moderate anxiety and tension and to relax muscles. It is a type of benzodiazepine. Also called Valium.

Case study: Cannabinoid hyperemesis syndrome in a patient with ALS

This case study of a patient with ALS and symptoms of cannabinoid hyperemesis syndrome emphasizes the need for research into the use of medicinal cannabis.

12 Jun 2019

New study examines non‐medical use of anti-anxiety medication

There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.

6 Jun 2019

Inflammation in the brain increases side-effects of hypnotic drugs

In a study recently published in the European Journal of Pharmacology researchers at Okayama University show how the presence of inflammation in the brain can increase its sensitivity to benzodiazepines.

7 Mar 2019

Study finds misuse of benzodiazepines to be highest among young adults

More than one in eight U.S. adults used benzodiazepines in the past year, up from previous reports. Misuse of the prescription drugs accounted for more than 17 percent of overall use, according to a study published online today in Psychiatric Services in Advance.

17 Dec 2018

Fentanyl surpasses heroin in cause of U.S. drug overdose deaths

According to a new report from health officials, Fentanyl – a synthetic opioid drug, is surpassing heroin as cause of drug overdose deaths in the United States. The report was released 12th of December 2018 in the CDC’s National Vital Statistics Report.

13 Dec 2018

Silver nanoparticles coated with anti-seizure drugs can kill brain-eating amoebae

Halloween is just around the corner, and some people will celebrate by watching scary movies about brain-eating zombies.

24 Oct 2018

Medical cannabis provides relief across dozens of health symptoms, study shows

Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects.

11 Sep 2018

Drug overdose continues to be a significant cause of death in Australia

A new report has come up with alarming numbers of deaths due to drug overdose among Australians. The report states that common sedatives and sleeping pills may be responsible for over 142 deaths each month due to their overdose.

27 Aug 2018

UT Southwestern study reveals structural information for major brain receptor

UT Southwestern researchers today published the first atomic structure of a brain receptor bound to a drug used to reverse anesthesia and to treat sedative overdoses.

28 Jun 2018

Brits cautioned against taking certain medicines abroad

The UK's Foreign Office has issued a statement warning Brits against carrying certain medications with them on holidays abroad.

7 Jun 2018

Low-dose anxiolytics can ameliorate social disadvantage related to trait anxiety

Psychologists speak of anxiety in two forms: "state" anxiety, which refers to anxiety arising from a particular situation; and "trait" anxiety, which refers to anxiety as part of a person's overall personality.

18 Jul 2017

Study identifies key mediator in learning process

The ability of the brain to respond and adapt to changes is scientifically called brain plasticity. This ability is the basis of all learning processes.

7 Apr 2017

EPFL scientists develop new computer model for better design of allosteric drugs

EPFL scientists have created a new computer model that can help better design of allosteric drugs, which control proteins "at a distance".

21 Feb 2017

Electronic health records could help identify people who have undiagnosed type 2 diabetes

In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed type 2 diabetes. The researchers got much more than they bargained for.

16 Feb 2016

AES releases new guideline to help physicians treat status epilepticus patients effectively

Status epilepticus - continuous or rapid sequential seizure activity for 30 minutes or more - is a medical emergency with a high mortality rate in both children and adults. Prompt and effective treatment is key; therefore the American Epilepsy Society has released a new guideline to help physicians, hospitals, and health systems treat patients effectively.

10 Feb 2016

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Alexza Pharmaceuticals, Inc. today announced interim results of its Phase 2a study of AZ-002 (Staccato alprazolam) in epilepsy patients. AZ-002 produced a dose-related decrease in mean Standardized Photosensivity Range (SPR), the primary endpoint in the study.

21 Dec 2015

Finding may pave way for much-needed treatments for people with epilepsy

An amino acid whose role in the body has been all but a mystery appears to act as a potent seizure inhibitor in mice, according to a study by researchers at Johns Hopkins.

22 Jun 2015

Veterans who died from drug overdoses also prescribed benzodiazepines for pain

In a recent study, nearly half of all veterans who died from drug overdoses while prescribed opioids for pain were also receiving benzodiazepines, or benzos, which are common medications for the treatment of anxiety, insomnia and alcohol withdrawal. Veterans prescribed higher doses of benzodiazepines while concurrently receiving opioids were at greater risk of overdose death than those on lower doses of benzodiazepines.

15 Jun 2015

Possible therapies to address cognitive symptoms in individuals with schizophrenia

By studying specially bred mice with specific developmental and cognitive traits resembling those seen in schizophrenia, UC San Francisco researchers have provided new evidence that abnormal rhythmic activity in particular brain cells contributes to problems with learning, attention, and decision-making in individuals with that disorder.

6 Mar 2015

Alexza begins Phase 2a study of AZ-002 for ARS-related epilepsy management

Alexza Pharmaceuticals, Inc. announced today that it has initiated a Phase 2a study of AZ-002 (Staccato alprazolam), which is being developed for the management of epilepsy in patients with acute repetitive seizures (ARS).

22 Jan 2015